(Q43896562)

English

Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients

scientific article published on 14 February 2002

Statements

Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients (English)
Constance A Benson
Harold A Kessler
Judith Feinberg
Richard Stryker
Melanie Thompson
Anthony J Japour

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit